Order Summary | License | Report Price | |
---|---|---|---|
Migraine Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Treatment (Acute Treatment, Preventive Treatment), By Therapeutic Class (Triptans, Acetylcholine Inhibitors/ neurotoxins, Ergot Alkaloids, NSAIDs, Ditans, CGRP Small molecule antagonists, CGRP monoclonal antibodies, Others), By Route of Administration (Oral, Injectables, Others), Countries and Companies Report TIPRE00029781 | Single User License | $ 3660 |
Single User License | $ 3660 | |
Grand Total | $ 3660 |